BRIDGE THERAPEUTICS
Bridge Therapeutics they provide service in chronic pain and opioid addiction.
BRIDGE THERAPEUTICS
Industry:
Biopharma Health Care Medical Pharmaceutical Service Industry
Founded:
2016-12-01
Address:
Birmingham, Alabama, United States
Country:
United States
Website Url:
http://www.bridgetherapeutics.com
Total Employee:
1+
Status:
Active
Contact:
+1 877 223-6949
Email Addresses:
[email protected]
Total Funding:
4 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Apple Mobile Web Clips Icon WordPress Google Universal Analytics Font Awesome
Similar Organizations
Edgewise Therapeutics
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
LENZ Therapeutics
LENZ Therapeutics is a late-stage clinical company developing innovative ophthalmic pharmaceutical products.
Scilex Pharmaceuticals
Scilex Pharmaceuticals is an emerging pharmaceutical company focused on acquiring and commercializing late-stage prescription products.
Current Employees Featured
Founder
Official Site Inspections
http://www.bridgetherapeutics.com
- Host name: 74-208-236-101.elastic-ssl.ui-r.com
- IP address: 74.208.236.101
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Bridge Therapeutics"
About Us - Bridge Therapeutics
Bridge Therapeutics is pursuing FDA approval of a patented drug combination for the treatment of chronic pain in opioid experienced patients.See details»
Bridge Therapeutics - Crunchbase Company Profile
Bridge Therapeutics is a pharmaceutical company.. When was the last funding …See details»
Bridge Therapeutics Inc. - LinkedIn
Bridge Therapeutics®, based in Birmingham, Ala., is an innovative development-stage specialty pharmaceutical company pursuing U.S. Food and Drug Administration (FDA) and European …See details»
bridge therapeutics
Bridge Therapeutics, 2437 S 130th Cir, Omaha, NE, 68144, United States 402.932.5147 [email protected] Powered by SquarespaceSee details»
Bridge Therapeutics 2025 Company Profile: Valuation, Funding ...
Information on valuation, funding, cap tables, investors, and executives for Bridge Therapeutics. Use the PitchBook Platform to explore the full profile.See details»
Bridge Therapeutics - Commercializing Safe Pain and Addiction …
Mr. Peara: Bridge is doing great. We are focused on solving a key part of the opioid crisis, which is providing safe pain relief. Since the year 2000, one million Americans have lost their lives to …See details»
Bridge Therapeutics - Craft
Bridge Therapeutics has 5 employees at their 1 location and $3 m in total funding,. See insights on Bridge Therapeutics including office locations, competitors, revenue, financials, executives, …See details»
Leadership Team | Bridge Therapeutics
Greg Sullivan, MD, who co-founded Bridge Therapeutics with the goal of helping patients beyond the walls of his own medical practice, has 25 years of experience conducting human studies …See details»
Bridge Therapeutics Inc. Information - RocketReach
Bridge Therapeutics Inc. is a Pharmaceutical Manufacturing, Manufacturing General, and Pharmaceutical company located in Birmingham, Alabama with $7 million in revenue and 6 …See details»
Bridge Therapeutics - F6S
Bridge Therapeutics - Bridge presents a golden investment opportunity to disrupt $40+ Billion markets by improving the healthcare of millions. The majority of the one million Americans who diSee details»
Bridge Therapeutics Company Profile | Management and
Find contact information for Bridge Therapeutics. Learn about their Pharmaceuticals, Manufacturing market share, competitors, and Bridge Therapeutics's email format.See details»
Startup of the Week: Bridge Therapeutics
May 15, 2022 Welcome to this week's Startup of the Week blog. This week we are introducing you to Tim Peara, President of Bridge Therapeutics -- a pharmaceutical company focused on …See details»
SCIENTIFIC ADVISORS | Bridge Therapeutics
Dr. Pergolizzi is the co-founder of NEMA Research, Inc., a specialty Contract Research Organization; he is also a former subcommittee member of the FDA’s Safe Use Initiative for …See details»
Bridge Therapeutics, Inc. - Drug pipelines, Patents, Clinical trials ...
100 Clinical Results associated with Bridge Therapeutics, Inc. Login to view more data 0 Patents (Medical) associated with Bridge Therapeutics, Inc. Login to view more data 2 News (Medical) …See details»
Nextsource | Company Profile | Bridge Therapeutics
Explore the company profile of Bridge Therapeutics (bridgetherapeutics.com) featuring business details and insights, funding data, industry info, employee numbers, and more.See details»
Investors - Bridge Therapeutics
Bridge Therapeutics is developing critically needed treatments for opioid use disorder and severe chronic pain. Opioid Use Disorder is a $6B market affecting 6 Million people. Chronic pain is a …See details»
Addiction & Pain Therapies | Bridge Therapeutics
Bridge Therapeutics are pursuing FDA approval of a patented drug combination for the treatment of chronic pain in opioid experienced patients.See details»
Press Releases Archives | Bridge Therapeutics
Bridge Therapeutics, today said that the MAT Act removes the outdated registration requirements on buprenorphine, making it possible for providers nationwide to prescribe it as they would any …See details»
News | Bridge Therapeutics
National Institute of Drug Addiction director Dr. Nora Volkow offers some of the latest updates around opioid crisis. In 2023, only 14.6% of people with a Substance Use Disorder received …See details»
Bridge Therapeutics Announces It Will Seek FDA Approval for BT …
Nov 7, 2019 Bridge Therapeutics Announces It Will Seek FDA Approval for BT-219, a Treatment for Opioid Dependence in the Coming MonthsSee details»